Legal & General Group Plc boosted its position in Masimo Corporation (NASDAQ:MASI) by 31.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 35,623 shares of the medical equipment provider’s stock after acquiring an additional 8,452 shares during the period. Legal & General Group Plc owned 0.07% of Masimo Corporation worth $3,250,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in MASI. JPMorgan Chase & Co. lifted its holdings in shares of Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock valued at $42,466,000 after purchasing an additional 45,833 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock valued at $60,175,000 after purchasing an additional 173,931 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock valued at $7,256,000 after purchasing an additional 700 shares in the last quarter. NN Investment Partners Holdings N.V. bought a new position in shares of Masimo Corporation in the second quarter valued at approximately $785,000. Finally, Quantitative Systematic Strategies LLC bought a new position in shares of Masimo Corporation in the second quarter valued at approximately $227,000. Institutional investors and hedge funds own 83.26% of the company’s stock.
A number of research firms have recently weighed in on MASI. BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a report on Monday, August 14th. BidaskClub lowered Masimo Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Stifel Nicolaus restated a “buy” rating and issued a $108.00 target price (up previously from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. Roth Capital raised their target price on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Finally, Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company’s stock. Masimo Corporation presently has a consensus rating of “Hold” and a consensus price target of $95.00.
In related news, Director Sanford Fitch sold 6,000 shares of the company’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $91.89, for a total value of $551,340.00. Following the sale, the director now owns 89,249 shares in the company, valued at approximately $8,201,090.61. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Rick Fishel sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $92.85, for a total value of $1,392,750.00. Following the completion of the sale, the insider now owns 35,022 shares in the company, valued at approximately $3,251,792.70. The disclosure for this sale can be found here. Insiders sold a total of 126,000 shares of company stock worth $11,732,930 in the last 90 days. 16.60% of the stock is currently owned by company insiders.
Masimo Corporation (NASDAQ:MASI) opened at 85.58 on Friday. The company has a market cap of $4.45 billion, a price-to-earnings ratio of 14.03 and a beta of 0.84. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The stock has a 50 day moving average price of $86.35 and a 200-day moving average price of $91.07.
Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.57 EPS. On average, analysts predict that Masimo Corporation will post $2.80 EPS for the current fiscal year.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.